GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: TD-1607 is from a series of glycopeptide-cephalosporin heterodimer antibacterial compounds, disclosed in a 2005 patent [2] and designed to treat serious infections caused by Gram-positive bacteria.
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| The MIC90 for antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) isolates is 0.008-0.06 μg/ml [3] |